AU2014298629B2 - Methods of preparing nicotinamide riboside and derivatives thereof - Google Patents

Methods of preparing nicotinamide riboside and derivatives thereof Download PDF

Info

Publication number
AU2014298629B2
AU2014298629B2 AU2014298629A AU2014298629A AU2014298629B2 AU 2014298629 B2 AU2014298629 B2 AU 2014298629B2 AU 2014298629 A AU2014298629 A AU 2014298629A AU 2014298629 A AU2014298629 A AU 2014298629A AU 2014298629 B2 AU2014298629 B2 AU 2014298629B2
Authority
AU
Australia
Prior art keywords
substituted
unsubstituted
formula
optionally
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014298629A
Other languages
English (en)
Other versions
AU2014298629A1 (en
Inventor
Kerri CROSSEY
Mark Doherty
Marie MIGAUD
Philip REDPATH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queens University of Belfast
Original Assignee
Queens University of Belfast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queens University of Belfast filed Critical Queens University of Belfast
Publication of AU2014298629A1 publication Critical patent/AU2014298629A1/en
Priority to AU2018211238A priority Critical patent/AU2018211238A1/en
Application granted granted Critical
Publication of AU2014298629B2 publication Critical patent/AU2014298629B2/en
Priority to AU2020201254A priority patent/AU2020201254B2/en
Priority to AU2022203196A priority patent/AU2022203196B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2014298629A 2013-07-29 2014-07-24 Methods of preparing nicotinamide riboside and derivatives thereof Active AU2014298629B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2018211238A AU2018211238A1 (en) 2013-07-29 2018-08-01 Methods of preparing nicotinamide riboside and derivatives thereof
AU2020201254A AU2020201254B2 (en) 2013-07-29 2020-02-21 Methods of preparing nicotinamide riboside and derivatives thereof
AU2022203196A AU2022203196B2 (en) 2013-07-29 2022-05-12 Method of preparing nicotinamide riboside and derivatives thereof

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1313465.5A GB201313465D0 (en) 2013-07-29 2013-07-29 Methods of preparing nicotinamide riboside and derivatives thereof
GB1313465.5 2013-07-29
PCT/EP2014/065971 WO2015014722A1 (en) 2013-07-29 2014-07-24 Methods of preparing nicotinamide riboside and derivatives thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2018211238A Division AU2018211238A1 (en) 2013-07-29 2018-08-01 Methods of preparing nicotinamide riboside and derivatives thereof

Publications (2)

Publication Number Publication Date
AU2014298629A1 AU2014298629A1 (en) 2016-02-11
AU2014298629B2 true AU2014298629B2 (en) 2018-08-16

Family

ID=49167061

Family Applications (4)

Application Number Title Priority Date Filing Date
AU2014298629A Active AU2014298629B2 (en) 2013-07-29 2014-07-24 Methods of preparing nicotinamide riboside and derivatives thereof
AU2018211238A Abandoned AU2018211238A1 (en) 2013-07-29 2018-08-01 Methods of preparing nicotinamide riboside and derivatives thereof
AU2020201254A Active AU2020201254B2 (en) 2013-07-29 2020-02-21 Methods of preparing nicotinamide riboside and derivatives thereof
AU2022203196A Active AU2022203196B2 (en) 2013-07-29 2022-05-12 Method of preparing nicotinamide riboside and derivatives thereof

Family Applications After (3)

Application Number Title Priority Date Filing Date
AU2018211238A Abandoned AU2018211238A1 (en) 2013-07-29 2018-08-01 Methods of preparing nicotinamide riboside and derivatives thereof
AU2020201254A Active AU2020201254B2 (en) 2013-07-29 2020-02-21 Methods of preparing nicotinamide riboside and derivatives thereof
AU2022203196A Active AU2022203196B2 (en) 2013-07-29 2022-05-12 Method of preparing nicotinamide riboside and derivatives thereof

Country Status (14)

Country Link
US (6) US10000519B2 (enExample)
EP (2) EP3027635B1 (enExample)
JP (1) JP6208352B2 (enExample)
KR (2) KR102414886B1 (enExample)
CN (2) CN105636973B (enExample)
AU (4) AU2014298629B2 (enExample)
BR (1) BR112016001774B1 (enExample)
CA (2) CA2918955C (enExample)
ES (1) ES2652654T3 (enExample)
GB (1) GB201313465D0 (enExample)
HK (1) HK1255037A1 (enExample)
MX (1) MX349969B (enExample)
WO (1) WO2015014722A1 (enExample)
ZA (1) ZA201802315B (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201313465D0 (en) 2013-07-29 2013-09-11 Queens University Of The Belfast Methods of preparing nicotinamide riboside and derivatives thereof
MX2016015997A (es) * 2014-06-02 2017-04-05 Glaxosmithkline Intellectual Property (No 2) Ltd Preparacion y uso de beta-d-nicotinamida ribosido cristalina.
CN106715455A (zh) 2014-06-06 2017-05-24 葛兰素史密斯克莱知识产权（第2 号）有限公司 烟酰胺核苷类似物及其药物组合物和用途
CA2956163C (en) * 2014-07-24 2023-01-10 W.R. Grace & Co.-Conn. Crystalline form of nicotinamide riboside
WO2016144660A1 (en) 2015-03-09 2016-09-15 W.R. Grace & Co.-Conn. Crystalline form of nicotinamide riboside
EP3271370B1 (en) * 2015-03-16 2023-06-21 Chromadex Inc. Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof
WO2017011788A1 (en) * 2015-07-15 2017-01-19 Cornell University Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives
EP3331894B1 (en) 2015-08-05 2021-02-17 Metro International Biotech, LLC Nicotinamide mononucleotide derivatives and their uses
GB2542881B (en) 2015-10-02 2020-01-01 Carr Andrew Crystal forms of ß-nicotinamide mononucleotide
US10611790B2 (en) * 2015-11-02 2020-04-07 Mitobridge, Inc. Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases
US11248018B2 (en) 2016-02-23 2022-02-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Process for preparation of nicotinamide riboside (NR) and cosmetic composition comprising (NR and a phosphate-binding agent
AU2017232930B2 (en) 2016-03-16 2021-03-25 ChromaDex Inc. B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
CA3021571C (en) 2016-04-20 2023-01-03 ChromaDex Inc. Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as nad+increasing precursors
WO2017218580A1 (en) 2016-06-14 2017-12-21 Rejuvenation Therapeutics Corporation Synthetic methods for the preparation of nicotinamide riboside and related compounds
GB2553001A (en) * 2016-08-19 2018-02-21 The Queen's Univ Of Belfast Lactone intermediates of nicotinamide riboside and nicotinate riboside
NZ803738A (en) 2016-11-11 2024-05-31 Chromadex Inc Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
US11071747B2 (en) 2016-11-29 2021-07-27 University Of Iowa Research Foundation Use of NAD precursors for breast enhancement
JP7136795B2 (ja) 2016-11-29 2022-09-13 ユニバーシティー オブ アイオワ リサーチ ファウンデーション 母体の健康および／または子の健康を向上させるためのｎａｄ前駆体の使用
US11286274B2 (en) 2017-06-19 2022-03-29 Mitopower Llc Nicotinamide riboside derivatives and their uses
WO2019006262A1 (en) * 2017-06-30 2019-01-03 Elysium Health, Inc. METHODS OF SYNTHESIZING NICOTINAMIDE RIBOSIDE
US11414407B2 (en) 2017-12-22 2022-08-16 Elysium Health, Inc. Crystalline forms of nicotinamide riboside chloride
WO2019122084A1 (en) 2017-12-22 2019-06-27 Stemtek Therapeutics, S.L. Process for the preparation of nicotinamide riboside chloride derivatives
WO2019152416A1 (en) 2018-01-30 2019-08-08 Metro International Biotech, Llc Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof
CN110283221A (zh) * 2018-03-19 2019-09-27 药源药物化学（上海）有限公司 杂环化合物的制备和纯化方法
CN110452277A (zh) * 2018-05-07 2019-11-15 明特奇点医疗科技(成都)有限公司 一种烟酰胺核糖的制备方法
WO2019226755A1 (en) * 2018-05-22 2019-11-28 Jumpstart Fertility Pty Ltd Amino acid salts of nicotinic acid ribosides as anti-aging agents
JP7515407B2 (ja) 2018-06-21 2024-07-12 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ニコチンアミドアデニンジヌクレオチド（ｎａｄ＋）前駆体及び少なくとも１種のケトン又はケトン前駆体を使用する組成物及び方法
CN108774278A (zh) * 2018-09-10 2018-11-09 张洪喜 一种制备尼克酰胺核苷盐的方法
KR102060374B1 (ko) * 2018-12-14 2019-12-30 주식회사 휴메딕스 지방알코올 컨쥬게이션된 니코틴아미드 리보사이드 유도체
EP3897666A2 (en) 2018-12-17 2021-10-27 Mitopower LLC Nicotinyl riboside compounds and their uses
US10618927B1 (en) 2019-03-22 2020-04-14 Metro International Biotech, Llc Compositions and methods for modulation of nicotinamide adenine dinucleotide
US11939348B2 (en) 2019-03-22 2024-03-26 Metro International Biotech, Llc Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
IL289941B2 (en) 2019-07-19 2025-07-01 Biosynth Ag Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof
CN114555619A (zh) * 2019-08-14 2022-05-27 麦德龙国际生物科技有限责任公司 用于烟酰胺腺嘌呤二核苷酸的差分调节的化合物和组合物
CN110642897B (zh) * 2019-09-27 2021-04-06 武汉一若生物材料有限公司 一种β-烟酰胺核糖氯化物的制备方法
CN110658224B (zh) * 2019-10-15 2022-11-22 中国中医科学院中药研究所 一种氢核磁定量分析技术测定nmn绝对含量的方法
CN111153953A (zh) * 2020-01-07 2020-05-15 杭州洁汉化工有限公司 一种烟酰胺核糖氯化物的高效合成方法
CN111454311B (zh) * 2020-04-03 2021-10-19 深圳市迪克曼科技开发有限公司 烟酰胺核糖的有机酸盐及其组合物与制备方法
CN111647032B (zh) * 2020-06-29 2023-02-24 上海舒泽生物科技研究所 一种β-烟酰胺单核苷酸的合成方法
CN111848710A (zh) * 2020-08-20 2020-10-30 深圳市迪克曼科技开发有限公司 烟酰胺核糖及其还原态、盐的制备方法
CN116390930A (zh) * 2020-09-15 2023-07-04 雀巢产品有限公司 用于由烟酰胺核糖核苷氯化物生产二氢烟酰胺核糖核苷的方法
CN112851730B (zh) * 2021-01-08 2023-02-21 厦门瑞林药业有限公司 一种nmn中间体nr氯化物合成方法
WO2022233923A1 (en) 2021-05-04 2022-11-10 Bohan & Co As. A process for synthesis of nicotinamide riboside chloride (nrcl)
KR20240020716A (ko) 2021-05-27 2024-02-15 메트로 인터내셔널 바이오테크 엘엘씨 니코틴산 모노뉴클레오타이드 및 이의 에스터의 결정질 고체 및 제조 및 사용 방법
JP2025514482A (ja) 2022-03-04 2025-05-02 ボーハン アンド カンパニー エーエス ニコチンアミド－β－リボシドトリアセテートクロリド（ＮＲＡ－Ｃｌ）からの１，４－ジヒドロニコチンアミドリボシド（ＮＲＨ）の合成方法
CN116462727A (zh) * 2023-04-23 2023-07-21 安徽瑞邦生物科技有限公司 一种β-烟酰胺核糖氯化物的制备方法
WO2024259359A2 (en) * 2023-06-14 2024-12-19 ChromaDex Inc. Nicotinamide riboside and derivatives thereof in intravenous formulations and methods of use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007061798A2 (en) * 2005-11-18 2007-05-31 Cornell Research Foundation, Inc. Nicotinoyl riboside compositions and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE349534T1 (de) 1991-10-23 2007-01-15 Cancer Rec Tech Ltd Bakterielle nitroreduktase zur reduzierung von cb 1954 und analogen davon in eine zytotoxische form
US6689760B1 (en) * 2000-07-10 2004-02-10 Enzrel Inc. Anti-mycobacterial compositions
WO2011081942A1 (en) * 2009-12-14 2011-07-07 Cornell University Activation and activators of sirt5
EP2542086A4 (en) * 2010-03-01 2013-09-04 Myrexis Inc COMPOUNDS AND ITS THERAPEUTIC USE
GB201313465D0 (en) 2013-07-29 2013-09-11 Queens University Of The Belfast Methods of preparing nicotinamide riboside and derivatives thereof
CN106715455A (zh) * 2014-06-06 2017-05-24 葛兰素史密斯克莱知识产权（第2 号）有限公司 烟酰胺核苷类似物及其药物组合物和用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007061798A2 (en) * 2005-11-18 2007-05-31 Cornell Research Foundation, Inc. Nicotinoyl riboside compositions and methods of use

Also Published As

Publication number Publication date
MX2016001211A (es) 2016-10-28
BR112016001774A2 (pt) 2017-08-01
KR20160043974A (ko) 2016-04-22
EP3027635A1 (en) 2016-06-08
US11584770B2 (en) 2023-02-21
ZA201802315B (en) 2023-02-22
AU2022203196A1 (en) 2022-06-02
WO2015014722A1 (en) 2015-02-05
ES2652654T3 (es) 2018-02-05
JP6208352B2 (ja) 2017-10-04
HK1255037A1 (en) 2019-08-02
US20200291055A1 (en) 2020-09-17
AU2018211238A1 (en) 2018-08-16
US20160168184A1 (en) 2016-06-16
US10815262B2 (en) 2020-10-27
CN105636973A (zh) 2016-06-01
CN105636973B (zh) 2018-06-01
US11981698B2 (en) 2024-05-14
US12252506B2 (en) 2025-03-18
KR102303966B1 (ko) 2021-09-24
BR112016001774B1 (pt) 2021-06-22
US20240101588A1 (en) 2024-03-28
CA3192957A1 (en) 2015-02-05
GB201313465D0 (en) 2013-09-11
CA2918955C (en) 2023-05-09
MX349969B (es) 2017-08-23
EP3321274A1 (en) 2018-05-16
US10000519B2 (en) 2018-06-19
JP2016530248A (ja) 2016-09-29
NZ716277A (en) 2021-03-26
US20220259250A1 (en) 2022-08-18
US20180186824A1 (en) 2018-07-05
AU2020201254A1 (en) 2020-03-12
EP3027635B1 (en) 2017-09-20
KR20210038718A (ko) 2021-04-07
US20240239831A1 (en) 2024-07-18
HK1218918A1 (en) 2017-03-17
CA2918955A1 (en) 2015-02-05
CN108707174A (zh) 2018-10-26
AU2014298629A1 (en) 2016-02-11
KR102414886B1 (ko) 2022-07-01
BR112016001774A8 (pt) 2020-01-21
AU2020201254B2 (en) 2022-05-26
AU2022203196B2 (en) 2023-11-23

Similar Documents

Publication Publication Date Title
US11981698B2 (en) Methods of preparing reduced nicotinamide riboside and derivatives thereof
CN86101400A (zh) 胞嘧啶核苷的制备
HK1218918B (en) Methods of preparing nicotinamide riboside and derivatives thereof
CN109641931A (zh) 核糖核酸h-磷酸酯单体的合成方法和使用了该单体的寡核苷酸合成
NZ716277B2 (en) Methods of preparing nicotinamide riboside and derivatives thereof
Lerner Preparation of 9-(5-deoxy-. alpha.-D-arabinofuranosyl) adenine from D-ribose
JPH0633263B2 (ja) ７−ヒドロキシグアニン誘導体及びその製造方法並びにそれを有効成分とする抗腫瘍剤
CN108929334B (zh) 一种吗啉二酮类天然生物碱及其衍生物的制备方法
TAKAMURA et al. Syntheses and antitumor activities of N6, N6-dimethyladenosine carboxylate analogues
Kim et al. Synthetic Studies Related to Ezomycins and Octosyl Acids. Synthesis of Heptofuranose Nucleosides
JPS6259716B2 (enExample)
JPWO1990015812A1 (ja) ２―アルキニルアデノシンの合成中間体、該合成中間体の製造法、該合成中間体を利用した２―アルキニルアデノシンの製造法および安定な２―アルキニルアデノシン誘導体

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)